Kevin Eggan, associate professor of stem cell and regenerative biology at FAS and Massachusetts General Hospital, is profiled for his work specializing in the study of amyotrophic lateral sclerosis (ALS), and how he is using stem cells as an important tool for understanding the progression of the disease.
